DAXOR CORP DXR
Nasdaq · XNAS · stock
Chart by TradingView
3/9
Piotroski F — financial health
3.74
Altman Z″ — distress risk · safe
-14.7%
Dividend payout · safe
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2011 | $1.4M | -$7.2M | $793,834 | -$6.6M | $36.2M |
| 2010 | $1.6M | $5.0M | $851,607 | -$6.0M | $47.0M |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Michel Robert J | Chief Financial Officer | 2026-06-23 | Grant | 12,000 | — |
| Feldschuh Michael Richard | Chief Executive Officer | 2026-06-23 | Grant | 30,000 | — |
| Feldschuh Jonathan Adam | Chief Scientific Officer | 2026-06-23 | Grant | 25,000 | — |
| Feldschuh Michael Richard | Chief Executive Officer | 2026-04-08 | Buy | 1,000 | $9.07 |
| Michel Robert J | Chief Financial Officer | 2026-03-31 | Buy | 1,000 | $9.90 |
| Jefferies John | Chief Medical Officer | 2026-03-20 | Buy | 3,656 | — |
| Jefferies John | Chief Medical Officer | 2026-03-20 | Buy | 2,285 | — |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 3.74 (safe)
- Working capital / assets 0.378
- Retained earnings / assets 0.289
- EBIT / assets -0.067
- Equity / liabilities 0.732
Source: SEC EDGAR filings · CIK 0000027367 · as of 2011-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.